Background & objective
Theanine (L-glutamylethylamide) contained in green tea is a functional food component that has been attracting attention due to its relaxation effect. It was shown that the ingredients added to the theanine formulations increased the absorption of theanine. If this mechanism can be elucidated, it would be possible to contribute to development of evidence-based formulations. In this study, we investigated the effect of ingredients in the formulations on the absorption of theanine in detail.
After oral administration of a mixture of theanine and additional components to Wistar rats the plasma concentration was determined by an HPLC and the pharmacokinetic parameters were calculated. In addition, a new system for evaluating intestinal blood flow was developed since the involvement of intestinal blood flow was considered as a factor that increased absorption of theanine.
Plasma concentration of theanine increased significantly in the combined use group with eight ingredients containing piperine as compared with theanine only group. Piperine would increase theanine absorption by increased blood flow, not an inhibition of metabolism. We succeeded to develop a visual and quantitative system to evaluate the effect of these ingredients directly including piperine on the intestinal blood flow using indocyanine green while maintaining physiological conditions.
Citation: Sato Y, Yamaguchi K, Ogawa M, Takekuma Y, Sugawara M (2021) An imaging approach for determining the mechanism of enhancement of intestinal absorption of an L-theanine supplement. PLoS ONE 16(6): e0253066. https://doi.org/10.1371/journal.pone.0253066
Editor: Yu-Hsuan Tsai, Shenzhen Bay Laboratory, CHINA
Received: December 5, 2020; Accepted: May 28, 2021; Published: June 11, 2021
Copyright: © 2021 Sato et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting information files.
Funding: This work was supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido and Grants-in-Aid for Scientific Research (C) (Grant number 16K00842, 20K07153) from the Japan Society for the Promotion of Science (JSPS). This research was partly supported by Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU), funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under “Support Program for Implementation of New Equipment Sharing System.” This research was also partially supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the MEXT and Japan Agency for Medical Research and Development (AMED).
Competing interests: The authors have declared that no competing interests exist.
Theanine (L-glutamyl ethylamide) is present in Japanese green tea and is one of the major components of amino acids . Theanine is contained not only in green tea leaves but also in other tea leaves . Drinking tea containing theanine has been found to have physiological effects: a relaxing effect, generation of an α-wave in the human brain , and reduction in blood pressure in rats with spontaneous hypertension and in high-stress-response adults [4–7]. The neuroprotective effects of theanine quantitatively have also been focused on since theanine is a derivative of L-glutamic acid, which is a neurotransmitter in the brain [8,9].
As described above, theanine has been shown to have a variety of effects and it has attracted much attention among functional food components. Some studies have shown the absorption mechanism of theanine [10–12]. Theanine would be transported by the Na+-independent neutral amino acids system L transporter. The theanine absorption would alter due to the transporter activation or inhibition, or ingredients in the formulation. Piperine, one of the ingredients in the formulation, was then focused on. Piperine, an alkaroid that is present in the fruits and roots of Piper longum and Piper nigrum linn, is an inhibitor of glucuronidation in the liver and intestine and is widely used enhancer of biological availability to improve the bioactivity of some components . Glucuronidase would not be involved in theanine metabolism. It was considered that this increase of absorption of theanine would not be derived from an inhibition of metabolism by piperine. Piperine has also been reported to modulate permeation properties of the intestine by causing alteration in membrane dynamics . However, this report did not directly show the effects of piperine itself. Elucidation of the mechanisms is important for the development of formulations based on scientific evidence.
In this study, the effect of the ingredients in the formulation on the absorption of theanine was investigated. In addition, since changes in blood flow were considered about the increase of plasma concentration of theanine, a new method for detecting change in blood flow visually was developed and analyzed in order to clarify the mechanism. This is the first report showing that piperine increases blood flow in the intestinal tract visually while maintaining a physiological condition. This system could be used to apply to detect the effects of other components on blood flow.
Materials and methods
Theanine powder and 8 ingredients for theanine formulations were kindly donated by FANCL Corp. (Kanagawa, Japan). Eight kinds of ingredients are as follows: Piper longum, creatine, proteoglycan, α-lipoic acid, cyanocobalamin, zanthoxyli fructus, pyridoxine hydrochloride and folic acid. 2-Aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) and leucine were purchased from Sigma-Aldrich Co., LLC (St. Paul, MN) and Kyowa Hakko Kogyo Co., Ltd. (Tokyo, Japan), respectively. Indocyanine green (ICG) (Diagnogreen®) was purchased from Daiichi-Sankyo Co., Ltd. (Tokyo, Japan). Other major reagents were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All of the reagents were of the highest grade available and used without further purification.
Male Wistar rats, aged 5 or 6 weeks (160–180 g in weight), were obtained from Jla (Tokyo, Japan). All of the rats were housed in plastic cages. The housing conditions were the same as those described previously . The experimental protocols were reviewed and approved by the Hokkaido University Animal Care Committee in accordance with the “Guide for the Care and Use of Laboratory Animals (approval number 18–0044)”.
Caco-2 cells obtained from RIKEN (Ibaraki, Japan) were maintained in a plastic culture dish (AS ONE, Osaka, Japan) as described previously . The cells were given a fresh medium every 2 days. When the cells had reached confluence after 4–6 days of culture, they were harvested with 0.25 mM trypsin and 0.2% EDTA in phosphate buffer saline (PBS; 137 mM NaCl, 2.68 mM KCl, 8.10 mM Na2PO4, 1.47 mM KH2PO4), resuspended, and seeded into a new dish.
Preparations of theanine, cephalexin formulations and ICG and piperine solution
Four kinds of theanine formulations were prepared as follows: theanine powder, theanine and a mixture of 8 ingredients, theanine and Piper longum, and theanine and a mixture of 7 ingredients (excluding Piper longum). All of the formulations contained 20 mg of theanine per milliliter. On the other hand, two kinds of cephalexin formulations were also prepared as follows: cephalexin powder, cephalexin and a mixture of 8 ingredients. These formulations contained 20 mg of theanine, or 5 mg of cephalexin per milliliter, respectively. The content of the additives in 1 mL containing a mixture of 7 or 8 ingredients in the theanine or cephalexin formulation is as follows: 100 mg of creatine, 60 mg of Piper longum, 20 mg of proteoglycan, 2.35 mg of α-lipoic acid, 0.80 mg of cyanocobalamin, 0.70 mg of zanthoxyli fructus, 0.50 mg of pyridoxine hydrochloride and 0.10 mg folic acid.
ICG solution (0.2 mg/mL water for injection) was prepared. Sodium heparin (1,000 U/mL) was diluted with saline 100 times, and a solution of saline and heparin was obtained. The solubility of piperine itself to water is low. Piperine solution was then suspended in a mixture of ethanol/propylene glycol/distilled water = 1/7/30 (v/v/v) based on previous reports (5 mg/mL, dose: 10 mg/kg weight) [17,18].
Oral administrations and collection of samples
To obtain data of plasma concentration profiles after oral administration of theanine or cephalexin, a total of 32 rats were used to detect statistical differences. The rats were fasted for 14–16 h before the experiments. Theanine (dose: 20 mg/kg weight) as a 2% solution (1 mL/kg) or cephalexin (dose: 10 mg/kg) as a 0.5% solution (2 mL/kg) was orally administered using a gastric sonde tube. The concentrations of theanine or cephalexin and other ingredients in each formulation excluding the formulation without piperine are all the same. Blood samples were collected and plasma samples were obtained as described previously . All of the samples were kept at -20°C until the assay.
Injection and observation of ICG
For data of time profile of intestinal blood flow, a total of 12 rats were used to be able to detect statistical differences. The rats were fasted for 14–16 h before the experiments. They were anesthetized by inhaled isoflurane  with 2.5–3.0% using laboratory animal anesthesia device SN-487 (Shinano manufacturing Co., Ltd., Tokyo, Japan). A small midline incision was made in the abdomen and the upper small intestine (15 cm) was radially exposed. A bile duct cannulation with a tube (0.5 μm tube, PE, Becton Dickinson, USA) for drainage of ICG was filled with heparin sodium (1,000 U/mL). ICG was administered by constant intravenous infusion from the tail vein at 5 mL/h with a syringe driver (TE-331S, TERUMO Corp, Tokyo, Japan). When administered intravenously, ICG is distributed only in blood and is excreted in bile. It was confirmed that the steady state reached 15 min after the start of injection of ICG. Fluorescence time lapse imaging was performed for 30 sec with pde-neo C10935-20 (Hamamatsu Photonics, K. K., Shizuoka, Japan) as the reference for the individual. The conditions used were as follows: excitation wavelength, 760 nm; emission wavelength, 830 nm; brightness, 4.5; contrast, 2.0; excitation light intensity, 3.0. Fluorescence intensity was set to the control level (intensity before administration of theanine and/or some ingredients). The test solution was then injected into the exposed intestine. After injection of the test solution, time-lapse imaging was performed up to 60 min. Three or more of the three-branched part of blood vessels present in the mesentery were selected for objective evaluation of fluorescence intensity in each rat. The fluorescence intensity at each part was quantified with ImageJ® for 30 sec from the start of imaging. The average value of 3 or more parts was used as an index of blood flow of the individual at the time point. The ratio of fluorescence intensity was then calculated with regards to the control (before the administration of test solution). Each rat was kept on a heater at about 37°C and the intestine was covered with sterile plastic wrapping and a humidifier with saline to prevent tissue from drying during the experiment except during fluorescence imaging.
After each experiment, rats were euthanized with excess sodium pentobarbital in accordance with the “Guide for the Care and Use of Laboratory Animals”. There were no animals who were dead or became severely ill during any studies.
Uptake study in Caco-2 cells
For uptake study, Caco-2 cells were seeded at a cell density of 1.0–2.0 × 105 cells/cm2 on a 24-well plastic plate (Corning Costar Inc., NY). The cell monolayers were given a fresh medium every 2 days and were used at 4–6 days for the uptake experiments. After removal of the growth medium, 0.5 mL of incubation buffer was added to wash each cell monolayer twice and 0.5 mL of incubation buffer containing theanine solution with or without BCH and leucine was added. The incubation buffer was the same as that described previously . The monolayers were incubated for the indicated time at 37°C. Each cell monolayer was rapidly washed twice with 0.5 mL ice-cold incubation buffer without a substrate at the end of the incubation period. Two hundred microliters of distilled water per well was added and incubated for 20 min at -80°C to break down the cell membrane. One hundred and twenty microliters of acetonitrile and 20 μL of ε-aminocaproic acid (final concentration of 27.8 ng/mL) as an internal standard were added to 100 μL of a sample, and the mixture was shaken. After centrifugation at 15,000 × g for 20 min at 4°C, the supernatant was taken as a sample for LC/MS injection. Uptake values were corrected against the protein content. The protein content was measured by the method of Lowry et al. with BSA as a standard .
The plasma concentration of theanine was determined using an HPLC system equipped with an L-7100 pump and an L-7485 FL detector (HITACHI, Tokyo, Japan) based on a previous report with some modifications . Five hundred microliters of distilled water and 100 μL of 200 μM ε-aminocaproic acid were added to 50 μL of a sample, and the mixture was shaken for 30 s. Then 150 μL of acetonitrile was added and the mixture was shaken. After centrifugation at 18,800 × g for 5 min at 4°C, 20 μL of the supernatant was taken and 180 μL of 0.2 M sodium borate buffer (pH 9.0) and 60 μL of 10 mM NBD-F (in acetonitrile) were added and the mixture was incubated for 40 min at room temperature for derivatization. Immediately, 240 μL of 50 mM hydrochloric acid was added to stop the reaction and samples for HPLC injection were obtained. The column for HPLC was a GL Sciences Inertsil® ODS-4 (3 μm in particle size, 3.0 mm in inside diameter × 150 mm) (Tokyo, Japan). The gradient elution was applied using 75 mM H3PO4/acetonitrile = 84/16 (v/v) (A) and 50 mM KH2PO4/acetonitrile/methanol = 40/21/39 (v/v/v) (B) as the mobile phase and programmed as follows: the gradient started with 100% of eluent A for 22.5 min and was decreased linearly down to 20% for 7.5 min. Then, it was decreased linearly again down to 0% for 15 min. This composition was held for a further 7.5 min before returning to 100% of eluent A immediately followed by re-equilibration for 7.5 min. Column temperature and flow rate were 30°C and 0.48 mL/min, respectively. The wavelengths of excitation and emission for detection were 470 and 540 nm, respectively. Twenty μL of a sample was injected into the HPLC system.
Chromatographic separations of uptake of theanine in Caco-2 cells were performed using an Acquity UPLC Quattro premier XE tandem quadrupole mass spectrometer (Waters Corp., Milford, MA, USA) with a COSMOSIL® HILIC packed column (3 μm in particle size, 3.0 mm in inside diameter × 150 mm) (Nakalai Tesque Inc., Kyoto, Japan) based on a previous report with some modifications . The gradient elution was applied using acetonitrile (A) and 10 mM ammonium acetate (B) as the mobile phase and programmed as follows: the gradient started with 70% of eluent A for 6 min and was decreased linearly down to 30% for 9 min. Then, it was returned linearly again up to 70% for 5 min for re-equilibration for 7.5 min. Column temperature and flow rate were 30°C and 0.4 mL/min, respectively. Five μL of a sample was injected into the UPLC system.
Some pharmacokinetic parameters of theanine were analyzed. The area under the curve (AUC) was calculated by the trapezoidal rule. T1/2 (half life) and Ke (elimination rate constant) were calculated by the following formulae.(1)(2)
Student’s t-test was used to determine the significance of differences between two group means. Statistical significance among means of more than two groups was determined by one-way analysis of variance (ANOVA) followed by Dunnett’s test. Statistical significance was defined as p<0.05. There were no excluding data in any experiments.
Effects of ingredients on the absorption of theanine
In the first part of this study, the plasma concentrations of theanine with and without a mixture of 8 ingredients were investigated up to 8 h after oral administration (Fig 1A). The concentration reached to a maximum concentration about 30 min after oral administration and theanine was eliminated slowly up to 8 h after administration. The concentration of theanine in the theanine + mixture of 8 ingredients group remained at a high level compared with that in the theanine powder group. There was no significant difference in the value of Tmax (time at maximum concentration) between these groups (Table 1). The maximum concentration (Cmax) in the theanine + mixture of 8 ingredients group was 14.7 ± 4.2 μg/mL whereas the value in the theanine powder group was 9.3 ± 2.3 μg/mL, respectively. The values of AUC in the theanine powder group and theanine + the mixture of 8 ingredients group were 15.0 ± 4.1 and 26.0 ± 8.0, respectively. It was shown that the mixture of 8 ingredients significantly increased the absorption of theanine, extent of absorption, not rate of absorption.
Each point represents the mean with S.D. of 5–6 measurements. Powder of theanine in 0.5% methylcellurose (closed circle) and a mixture of theanine and eight ingredients (closed square) were administered (A). Powder of theanine in 0.5% methylcellurose (closed circle), a mixture of theanine and Piper longum (closed triangle), and a mixture of theanine and seven ingredients excluding Piper longum (open square) were administered (B). Blood samples were obtained up to 8 h after administration. The dose of theanine in all groups was 25 mg/kg body weight.
It was then investigated the effects of the ingredients on the absorption of theanine. Piper longum in the ingredients was focused on since it contains piperine. It was hypothesized that piperine increases the absorption of theanine. Theanine + Piper longum was administered and the concentration was determined. At 15 min after administration, the plasma concentration of theanine was increased in the theanine + Piper longum group compared with that in the theanine powder group (Fig 1B). The value of AUC was not significantly different but tended to increase in the theanine + Piper longum group (Table 1). The effects of ingredients other than Piper longum were also investigated. There was little alteration in the plasma concentration profile in the theanine + mixture of 7 ingredients (excluding Piper longum) group compared with that in the theanine powder group. It was shown that these 7 ingredients did not contribute to the improvement in absorption of theanine.
It was speculated that theanine has high membrane permeability and that its absorption is dependent on intestinal blood flow. To confirm this speculation, cephalexin was also administered and the plasma concentration profiles were investigated as a preliminary test. The concentration of cephalexin reached to a maximum concentration about 1.5 h after oral administration and then cephalexin was eliminated gradually up to 8 h after administration (S1 Fig). The concentration of cephalexin in the cephalexin + 8 ingredients group remained at a high level compared with that in the cephalexin powder group. The values of Cmax and AUC in the cephalexin + mixture of 8 ingredients group were larger than those in the cephalexin powder group, though the differences were not significant (S1 Table). The values of Tmax, T1/2 and Ke were almost the same in the two groups.
Effects of ingredients on the uptake of theanine into Caco-2 cells
Theanine was shown to be mainly transported by the Na+-independent neutral amino acids system L transport pathway . It was hypothesized that the ingredients strengthen the transporter activity. Caco-2 cells were used to investigate the effects of ingredients on the uptake of theanine. The time course of theanine accumulation is shown in Fig 2A. The accumulation of theanine increased for 40 min after the start of incubation. However, there was no linearity even at 5 min after the start of incubation. Thus, the initial accumulation was evaluated at 3 min. The concentration-dependence of theanine accumulation by Caco-2 cells was then investigated. It was confirmed that accumulation of theanine increased in a dose-dependent manner up to about 300 μM (Fig 2B). It was therefore evaluated the accumulation of theanine at 200 μM since that concentration was sufficient to determine the accumulation. It was then investigated whether the transporter influenced on the uptake of theanine into Caco-2 cells using BCH and leucine, inhibitors of the system L transport system. BCH and leucine significantly inhibited the uptake of theanine into Caco-2 cells by 50% and 80%, respectively (Fig 2C). On the other hand, there was no significant difference in the accumulation of theanine between the control group and mixture of 8 ingredients group.
The uptake of theanine (500 μM) at 1, 5, 10, 20 and 40 min (A) and the accumulation of theanine (50, 100, 200 and 300 μM) (B) were measured at pH 7.4 at 37°C. The accumulation of theanine (200 μM) was measured at pH 7.4 at 37°C in the absence (control) and presence of a mixture of ingredients or inhibitors (5 mM of BCH or leucine) (C). The concentration of theanine was determined using an LC/MS. Each point represents the mean with S.D. of 3–4 measurements. **; significantly different from the control at p<0.01.
Evaluation of intestinal blood flow by fluorescence imaging using ICG
It was focused on the use of ICG as a means for visually evaluating the possible alteration of intestinal blood flow caused by these ingredients. ICG was injected continuously from the tail vein and a steady state was confirmed (Fig 3A and S2 Fig). The physiological condition of the intestine must be maintained, although the intestine was exposed to the outside of abdominal cavity in this study. Saline was then administered into the intestine as a control. There was no alteration in fluorescence intensity of the intestine up to 60 min after administration (Fig 3B). It was also confirmed that the physiological condition and the peristalsis of the intestine were maintained throughout the experiments (Fig 3C and 3D).
Intestine and mesentery after injection of ICG (A) and time course of intestinal blood flow after injection of saline (B). Visualization of the intestine after administration of theanine and a mixture of ingredients in a bright field (C) and a dark field (D) at 0, 15, 30 and 60 min. The three-branched part of blood vessels present in the mesentery (arrows) was selected for evaluation of the fluorescence intensity in each rat (A). ICG was administered by constant intravenous infusion from the tail vein at 5 mL/h with a syringe driver. At 15 min after the start of injection, fluorescence time lapse imaging was obtained for 30 sec with pde-neo C10935-20. Saline was then administered into the intestine and fluorescence time lapse imaging was also obtained for 1 h after administration. The average of the fluorescence intensity for 30 sec from the start of imaging was calculated with ImageJ®. Each point represents the mean with S.D. of 3 measurements (B). Appearances of the intestine in bright (C) and dark (D) fields at (i) 0, (ii) 15, (iii) 30 and (iv) 60 min after administration of a mixture of ingredients were obtained. Each appearance was shown as a representative of the three measurements.
Effects of piperine and some ingredients on intestinal blood flow
It was next investigated the effects of piperine and some ingredients on intestinal blood flow (Fig 4). There was little alteration in the ratio of intestinal blood flow up to 60 min after injection in the vehicle group and the saline group. On the other hand, the intestinal blood flow was confirmed to increase largely up to 15 min after injection in the piperine (10 mg/kg: positive control). The mixture of 8 ingredients including piperine (23 μg/kg) also increased intestinal blood flow in the first of 15 min after injection and the increased intestinal blood flow decreased slowly. It was shown that the mixture of 8 ingredients increased the absorption of theanine via an increase in intestinal blood flow.
ICG was administered by constant intravenous infusion from the tail vein at 5 mL/h with a syringe driver. At 15 min after the start of injection, fluorescence time lapse imaging was obtained for 30 sec with pde-neo C10935-20. A vehicle (ethanol/propylene glycol/distilled water = 1/7/30 (v/v/v)) (triangle) or piperine (10 mg/kg) (circle) or a mixture of ingredients (dose of piperine: 23 μg/kg) (square) was then administered into the intestine and fluorescence time lapse imaging was also obtained for 1 h after administration. The average of fluorescence intensity for 30 sec from the start of imaging was calculated with ImageJ®. Each point represents the mean with S.D. of 3 measurements.
L-theanine is a component of green tea that has various functions. Various supplements formulations of theanine have been developed. It is known that additives in supplements and foods often affect the absorption of the main component, but the detailed mechanisms by which absorption of main component is affected have not been elucidated in many cases. We previously showed some specific additives, oleyl polyethylene acetic acids, increased the absorption of coenzyme Q10 . In this study, the effect of ingredients in the formulation on the absorption of theanine was investigated. A new imaging method for detecting change in blood flow was also developed to clarify the effect in detail.
In the first part of this study, the plasma concentration profile of theanine after oral administration of theanine powder was confirmed. The concentration reached to a maximum concentration about 30 min after oral administration and then theanine was eliminated gradually up to 8 h after administration. These results are consistent with the results of a previous report . It was then confirmed the effects of ingredients other than theanine on the plasma concentration of theanine. Eight ingredients significantly increased the plasma concentration of theanine compared with that in the case of administration of theanine powder, not rate of absorption of theanine (Fig 1A, Table 1). In these ingredients, we focused on piperine, which is known as an enhancer of the absorption of various components, in Piper longum [26,27]. Piperine is known to be a potent inhibitor of cytochrome P450, particularly CYP3A4 and CYP1A2 . Piperine is also known as an inhibitor of glucuronidase [28,29]. It was reported that theanine was hydrolyzed into glutamic acid and ethylamine . It was considered that CYP and glucuronidase are not probably involved in theanine metabolism. Therefore, an increased in blood flow is considered as another mechanism of increased theanine absorption.
It was next hypothesized that piperine affected the blood flow and increased the absorption of theanine. The plasma concentration of theanine increased in the theanine + Piper longum group compared with that in the theanine powder group (Fig 1B). The value of AUC was not significantly different but tended to increase in the theanine + Piper longum group (Table 1). On the other hand, there was little alteration of the plasma concentration profile in the theanine + mixture of 7 ingredients (excluding Piper longum) group compared with that in the theanine powder group. It was shown that the mixture of 7 ingredients did not contribute to the increase of absorption of theanine but that the mixture of 8 ingredients including Piper longum increased theanine absorption in a synergistic manner.
Theanine has been shown to be transported rapidly by the Na+-independent neutral amino acids system L transport pathway . It was speculated that theanine has high membrane permeability and that its absorption is dependent on intestinal blood flow. It was also hypothesized that the mechanism by which the absorption of theanine is improved is an increase in intestinal blood flow. To confirm the hypothesis, cephalexin was then administered to rats. It was not needed to consider the influence of inhibition of metabolism because cephalexin is excreted into urine as an unchanged form. Cephalexin has high membrane permeability and is transported into blood by PEPT1 (peptide transporter 1) . The plasma concentration profile of cephalexin after oral administration was obtained at the start time of 14:00 in all experiments since there is a circadian variation in the expression of PEPT1 . The concentration of cephalexin in the cephalexin + 8 ingredients group remained at a high level compared with that in the cephalexin powder group (S1 Fig). The values of Cmax and AUC in the cephalexin + mixture of 8 ingredients group were larger than those in the cephalexin powder group, though the differences were not significant (S1 Table). These results indicated that the mixture of 8 ingredients including Piper longum increased the absorption of cephalexin as well as that of theanine. The results suggested that these ingredients increased intestinal blood flow.
It was next hypothesized that the ingredients strengthen the transporter activities. The effects of the ingredients on the uptake of theanine were investigated using Caco-2 cells. BCH and leucine inhibited the uptake of theanine into Caco-2 cells by 50% and 80%, respectively (Fig 2C). On the other hand, there was no significant difference in the accumulation of theanine between the control group and the mixture of 8 ingredients group. These results suggested that the mixture of 8 ingredients did not contribute to the activity of the transporter. The results also suggested that the limiting factor of the increase in absorption of theanine is based on an increase in intestinal blood flow rather than permeation of the cell membrane.
Piper longum and piperine have been reported to increase the bioavailability of some components . Their group reported that the mechanism would promote rapid absorption from the gastrointestinal tract and protect the components from being metabolized in its first passage though the liver after being absorbed. Another group also reported the mechanism of Trikatu and individual components and piperine . However, those results do not directly demonstrate that Piper longum or piperine activate the intestinal movements and effects on the blood flow. Kono et al. reported that colonic blood flow was measured by laser Doppler tissue blood flowmetry . The colonic vascular conductance was calculated as the quotient of mean blood flow divided by mean arterial blood pressure. It was then focused on the use of ICG and set out to establish the evaluation of the alteration of possible intestinal blood flow by these ingredients visually and quantitatively. It is possible to observe blood flow distribution, leakage to tissues lymphatic flow in the body and from the body surface in take advantage of property that ICG emits fluorescence when irradiated specific excitation light . Injected ICG is distributed only in blood and is excreted into bile . It was speculated that we could evaluate intestinal blood flow as fluorescence intensity since a region with large blood flow increases fluorescence intensity based on the properties of ICG. There have been few studies in which intestinal blood flow was evaluated directly with ICG. Behrendt et al. observed the intestinal transit using ICG though no time-profiles after intestinal treatment was shown . Wada et al. also reported that colonic blood flow was analyzed using ICG and some parameters were calculated . There were some differences of parameters in their report. However, it was considered necessary to observe several time points after oral administration to see the effects of orally administered ingredients on the intestine. A steady state of ICG and no alteration in fluorescence intensity of the intestine up to 60 min after administration of saline were confirmed (Fig 3B and S2 Fig). The physiological condition and peristalsis of the intestine through experiments had also checked (Fig 3C and 3D). Then the effects of piperine and some ingredients on intestinal blood flow were investigated (Fig 4). A positive control of piperine (10 mg/kg) based on previous reports [14,25] increased intestinal blood flow up to about 135% for 15 min after the start of injection. Eight ingredients including piperine (23 μg/kg) also increased intestinal blood flow to about 120% in the first of 15 min after the start of injection and the increased intestinal blood flow then decreased gradually up to 60 min. The extent of enhancement of intestinal blood flow by the eight ingredients including piperine was smaller than that by the positive control, though consideration should be given to the small doses (about 1/500).
As a limitation of this study, it is difficult to explain to rate of increased absorption of theanine only by increasing blood flow. In addition to this increased blood flow, other mechanisms may be involved in the increased absorption of theanine by these 8 ingredients. Further studies are needed to clarify these mechanisms and contribute to evidence-based formulation development.
Plasma concentration of theanine increased significantly in the group with theanine and a mixture of 8 ingredients including Piper longum. The effect of piperine in the Piper longum on the blood flow was focused to investigate the mechanism in detail. It succeeded in visual and quantitative evaluation of intestinal blood flow using ICG in physiological conditions. It was also confirmed improvement in the absorption of theanine and enhancement of intestinal blood flow by the eight ingredients including piperine. These results could be applied to elucidate the absorption mechanism of other components based on the scientific evidence. Further studies to apply this system to evaluation of the intestinal blood flow are in progress.
S1 Fig. Plasma concentration of cephalexin after oral administration of theanine powder and/or a mixture of ingredients.
The dose of cephalexin in both groups was 10 mg/kg body weight. Each point represents the mean with S.D. of 5 measurements. Powder of cephalexin in 0.5% methylcellurose (closed circle) and a mixture of theanine and eight ingredients (open circle) were administered.
S2 Fig. Confirmation of a steady state of ICG for 30 sec at 15 min after injection.
ICG was administered by constant intravenous infusion from the tail vein at 5 mL/h with a syringe driver. At 15 min after the start of injection, fluorescence time lapse imaging was obtained for 30 sec with pde-neo C10935-20. The fluorescence intensity from time lapse imaging was quantified with ImageJ®. This is the state before the administration of test solution.
The authors thank Dr. Masatoshi Honjo, Mr. Tsuyoshi Sakurada, Mr. Kota Nakagawa and Mr. Tomoki Adachi in FANCL Corp. for providing theanine and some ingredients.
- 1. Sakato Y. The chemical constituents of tea; III. A new amide theanine. Nippon Nogeikagaku. 1949;23: 262–267. https://doi.org/10.1271/nogeikagaku1924.23.268.
- 2. Keenan EK, Finnie MDA, Jones PS, Rojers PJ, Priestley CM. How much theanine in a cup of tea? Effects of tea type and method of preparation. Food Chem. 2011;125: 588–594. https://doi.org/10.1016/j.foodchem.2010.08.071.
- 3. Juneja LR, Chu CD, Okubo T, Nagato Y, Yokogoshi H. L-theanine- a unique acid of green tea and its relaxation effect in humans. Trends Food Sci. Technol. 1999;10: 199–204. https://doi.org/10.1016/S0924-2244(99)00044-8.
- 4. Yokogoshi H, Kato Y, Sagesaka YM, Takihara-Matsuura T, Kakuda T, Takeuchi N. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci. Biotech. Biochem. 1995;59: 615–618. https://doi.org/10.1271/bbb.59.615.
- 5. Rogers PJ, Smith JE, Heatherley SV, Pleydell-Pearce CW. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacol. 2008;195: 569–577. https://link.springer.com/article/10.1007/s00213-007-0938-1.
- 6. Yoto A, Motoki M, Murao S, Yokogoshi H. Effects pf L-theanine or caffeine intake on changes in blood pressure under physical and psychological stress. J. Physiol. Anthropol. 2012;31: 28. pmid:23107346
- 7. White DJ, de Klerk S, Woods W, Gondalia S, Noonan C, Scholey AB. Anti-stress, behavioural and magnetoencephalography effects of an L-theanine-based nutrient drink: A randomized, double-blind, placebo-controlled, crossover trial. Nutrients. 2016;8: 53. pmid:26797633
- 8. Yokogoshi H, Kobayashi M, Mochizuki M, Tarashima T. Effect of theanine, R-Glutamylehyladmide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem. Res. 1998;23: 667–673. pmid:9566605
- 9. Yamada T, Terashima T, Kawano S, Furuno R, Okubo T, Juneja LR, et al. Theanine, γ-Glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats. Amino Acids. 2009;36: 21–27. pmid:18196445
- 10. Unno T, Suzuki Y, Kakuda T, Hayakawa T, Tsuge H. Metabolism of theanine, γ-Glutamylethylamide, in rats. J. Agric. Food Chem. 1999;47: 1593–1596. pmid:10564022
- 11. Lu Y, Zhang J, Wan X, Long M, Li D, Lei R, et al. Intestinal transport of pure theanine and theanine in green tea extract: Green tea components inhibit theanine absorption and promote theanine excretion. Food Chem. 2011;125: 277–281. https://doi.org/10.1016/j.foodchem.2010.09.027.
- 12. Yamamoto S, Kimura T, Tachiki T, Anzai N, Sakurai T, Ushimaru M. The involvement of L-type amino acid transporters in theanine transport. Biosci. Biotech. Biochem. 2012;76: 2230–2235. pmid:23221699
- 13. Di X, Wang X, Di X, Liu Y. Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats. J. Pharm. Biomed. Anal. 2015;115: 144–149. pmid:26201645
- 14. Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: Influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine. 2002;9: 224–231. pmid:12046863
- 15. Sato Y, Kobayashi M, Itagaki S, Hirano T, Noda T, Mizuno S, et al. Protective effect of lutein after ischemia-reperfusion in the small intestine. Food Chem. 2011;127: 893–898. pmid:25214075
- 16. Takekawa Y, Sato Y, Yamaki Y, Imai M, Noto K, Sumi M, et al. An approach to improve intestinal absorption of poorly absorbed water-insoluble components via Niemann-Pick C1-Like 1. Biol. Pharm. Bull. 2016;39: 301–307. pmid:26934923
- 17. Bajad S, Singla AK, Bedi KL. Liquid chromatographic method for determination of piperine in rat plasma: application to pharmacokinetics. J. Chromato. B. 2002;776: 245–249. pmid:12138007
- 18. Izgrelov D, Domb AJ, Hoffman A. The effect of piperine on oral absorption of cannabinol following acute vs. chronic administration. Eur. J. Pharm. Sci. 2020;148: 105313. pmid:32198013
- 19. Sato Y, Kobayashi M, Itagaki S, Hirano T, Noda T, Mizuno S, et al. Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein. Biopharm. Drug Dispos. 2011;32: 151–158. pmid:21321944
- 20. Sato Y, Joumura T, Nashimoto S, Yokoyama S, Takekuma Y, Yoshida H, et al. Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 2018;127: 171–176. pmid:29428792
- 21. Sato Y, Kondo Y, Sumi M, Takekuma Y, Sugawara M. Intracellular uptake mechanism of lutein in retinal pigment epithelial cells. J. Pharm. Pharmaceut. Sci. 2013;16: 494–501. pmid:24021296
- 22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951;193: 265–275. pmid:14907713.
- 23. Desai MJ, Gill MS, Hsu WH, Armstrong DW. Pharmacokinetics of theanine enantiomers in rats. Chirality. 2005;17: 154–162. pmid:15704209
- 24. Dai W, Xie D, Lu M, Li P, Lv H, Yang C, et al. Characterization of white tea metabolome: Comparison against green and black tea by a nontargeted metabolomics approach. Food Res. Int. 2017;96: 40–45. pmid:28528106
- 25. Sato Y, Yokoyama S, Yamaki Y, Nishimura Y, Miyashita M, Maruyama S, et al. Enhancement of intestinal absorption of coenzyme Q10 using emulsions containing oleyl polyethylene acetic acids. Eur. J. Pharm. Sci. 2020;142: 105144. pmid:31730802
- 26. Izgrelov D, Cherniakov I, Bier GA, Domb AJ, Hoffman A. The effect of piperine pro-nano lipospheres on direct intestinal phase II metabolism: The raloxifene paradigm of enhanced oral bioavailability. Mol. Pharm. 2018;15: 1548–1555. pmid:29537855
- 27. Wang R, Han J, Jiang A, Huang R, Fu T, Wang L, et al. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine. Int. J. Pharm. 2019;561: 9–18. pmid:30817985
- 28. Shamsi S, Tran H, Tan RSJ, Tan ZJ, Lim LY. Curcumin, piperine, and capsaicin: A comparative study of spice-mediated inhibition of human cytochrome P450 isozyme activities. Drug Metab. Dispos. 2017;45: 49–55. pmid:27821437
- 29. Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crt. Rev. Food Sci. Nutr. 2007;47: 735–748. pmid:17987447
- 30. Mitsuoka K, Tamai I, Morohashi Y, Kubo Y, Saitoh R, Tsuji A, et al. Direct evidence for efficient transport and minimal metabolism of L-cephalexin by oligopeptide transporter 1 in budded baculovirus fraction. Biol. Pharm. Bull. 2009;32: 1459–1461. pmid:19652390
- 31. Hironaka T, Itokawa S, Ogawara K, Higaki K, Kimura T. Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats. Pharm. Res. 2009;26: 40–50. pmid:18784906
- 32. Annamalai AR, Manavalan R. Effects of ‘Trikatu’ and its individual components and piperine on gastro intestinal tracts: Trikatu- a bioavailable enhancer. Indian Drugs. 1990;27: 595–604.
- 33. Kono T, Koseki T, Chiba S, Ebisawa Y, Chisato N, Iwamoto J, et al. Colonic vascular conductance increased by Dikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein. J. Surg. Res. 2008;150: 78–84. pmid:18561951
- 34. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J. Clin. Invest. 1960;39: 592–600. pmid:13809697
- 35. Beherendt FF, Tolba RH, Overhaus M, Hirner A, Minor T, Kalff JC. Indocyanine green fluorescence measurement of intestinal transit and gut perfusion after intestinal manipulation. Eur. Sur. Res. 2004;36: 210–218. pmid:15263826
- 36. Wada T, Kawada K, Hirai K, Toda K, Iwamoto M, Hasegawa S, et al. Enhanced anastomotic healing by Daikenchuto (TJ-100) in rats. Sci. Rep. 2018;8: 1091. pmid:29348453